IP Library › Assignment 071646/0715
Patent Assignment
Reel/Frame 071646/0715

Assignment of Assignor's Interest

Recorded: 2025-07-09 Pages: 16
Assignors
BELLENIE, BENJAMIN RICHARD
Executed: 2022-10-21
BRENNAN, ALFIE
Executed: 2022-10-22
CHEUNG, KWAI MING JACK
Executed: 2022-10-19
DAVIS, OWEN ALEXANDER
Executed: 2022-10-25
HARNDEN, ALICE CLAIRE
Executed: 2022-10-21
HOELDER, SWEN
Executed: 2022-11-01
HUCKVALE, ROSEMARY
Executed: 2022-11-15
Assignees
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
123 OLD BRAMPTON ROAD, LONDON, SW7 3RP, UNITED KINGDOM
CANCER RESEARCH TECHNOLOGY LIMITED
2 REDMAN PLACE, LONDON, UNITED KINGDOM
Covered Property (1)
[1,4]Oxazepino[2,3-C]Quinolinone Derivatives as BCL6 Inhibitors
Application: 17/768,174 →
Publication: US 2024/0217987
Related Assignments (1)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 30, 2022
From: BELLENIE, BENJAMIN RICHARD; BRENNAN, ALFIE; CHEUNG, KWAI MING JACK; HARNDEN, ALICE CLAIRE
To: THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
Reel/Frame 060938/0213 →